JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robbins, W. R.
Right arrow Articles by Pappagallo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robbins, W. R.
Right arrow Articles by Pappagallo, M.

Anesthesia & Analgesia, Vol 86, 579-583, Copyright © 1998 by International Anesthesia Research Society

GENERAL ARTICLES

Treatment of intractable pain with topical large-dose capsaicin: preliminary report

WR Robbins, PS Staats, J Levine, HL Fields, RW Allen, JN Campbell and M Pappagallo
Department of Anesthesia, University of California-San Francisco, 94143, USA.

Complex regional pain syndromes (CRPS) and neuropathic pain are often poorly controlled by conventional pharmacologic interventions. We administered 8-methyl-N-vanillyl-noneamide (capsaicin) at doses of 5%- 10% to individuals with such disorders in this trial. Previous limitations to trials with larger-dose, topical concentrations of capsaicin included intense burning sensations experienced after application. To enable patients to tolerate the high concentrations, we first performed regional anesthesia. All patients reported at least some relief. Of 10 patients, 9 obtained substantial analgesia that lasted 1-18 wk. At Week 1 after therapy, the mean verbal analog scale (VAS) scores decreased from 8.0 to 3.0. At Week 4 after therapy, mean VAS score was 4.5. Analgesia lasted from < 1 wk (1 patient) to more than 50 wk (1 patient). Patients received one to eight treatments. With one exception, patients receiving more than one treatment obtained additional relief with subsequent treatment. Pain responsive to opioids was the only side effect of treatment. Large-dose capsaicin administered with regional anesthesia may effectively minimize refractory CRPS and neuropathic pain. A double-blind, placebo- controlled study in patients with bilateral peripheral neuropathy using epidural anesthesia with and without large-dose topical capsaicin is in progress. IMPLICATIONS: Sensory neuropathies are associated with many diseases. Pain from these disorders can produce greater disability than the primary disease processes themselves. Currently available therapies are limited. However, the intermittent application of large-dose topical capsaicin may provide significant pain relief, decrease chronic analgesic dependence, and decrease aggregate health care expenditures.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
J.-W. Shin, C. Pancaro, C. F. Wang, and P. Gerner
The Effects of Resiniferatoxin in an Experimental Rat Thoracotomy Model
Anesth. Analg., January 1, 2010; 110(1): 228 - 232.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. M. Simpson, S. Brown, J. Tobias, and For the NGX-4010 C107 Study Group
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
Neurology, June 10, 2008; 70(24): 2305 - 2313.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. Sawynok
Topical and Peripherally Acting Analgesics
Pharmacol. Rev., March 1, 2003; 55(1): 1 - 20.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
D. G. Witte, S. C. Cassar, J. N. Masters, T. Esbenshade, and A. A. Hancock
Use of a Fluorescent Imaging Plate Reader-Based Calcium Assay to Assess Pharmacological Differences between the Human and Rat Vanilloid Receptor
J Biomol Screen, October 1, 2002; 7(5): 466 - 475.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. R. Grant, A. E. Dubin, S.-P. Zhang, R. A. Zivin, and Z. Zhong
Simultaneous Intracellular Calcium and Sodium Flux Imaging in Human Vanilloid Receptor 1 (VR1)-Transfected Human Embryonic Kidney Cells: A Method to Resolve Ionic Dependence of VR1-Mediated Cell Death
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 9 - 17.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
R. B. Layzer
Hot Feet: Erythromelalgia and Related Disorders
J Child Neurol, March 1, 2001; 16(3): 199 - 202.
[Abstract] [PDF]

Home page
 Journal of the American Dental AssociationHome page
M. PADILLA, G. T. CLARK, and R. L. MERRILL
TOPICAL MEDICATIONS FOR OROFACIAL NEUROPATHIC PAIN: A REVIEW
J Am Dent Assoc, February 1, 2000; 131(2): 184 - 195.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Szallasi and P. M. Blumberg
Vanilloid (Capsaicin) Receptors and Mechanisms
Pharmacol. Rev., June 1, 1999; 51(2): 159 - 212.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Wu, M. Ringkamp, T. V. Hartke, B. B. Murinson, J. N. Campbell, J. W. Griffin, and R. A. Meyer
Early Onset of Spontaneous Activity in Uninjured C-Fiber Nociceptors after Injury to Neighboring Nerve Fibers
J. Neurosci., April 15, 2001; 21(8): RC140 - RC140.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1998 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1998 by the International Anesthesia Research Society.